Offerings and Capabilities
Strategy & Portfolio Analysis

Pharmaceutical companies continuously need to determine their strategy on how to grow portfolios filled with healthcare innovations and provide them to patients and caregivers globally. A rapidly changing healthcare environment, new research discoveries, reimbursement hurdles, and uncertain commercial success requires manufacturers to make tough decisions about which treatments to pursue and in which countries, typically years before they will achieve their full potential.

Our Strategy & Portfolio Analysis (S&PA) Center of Excellence has decades of experience helping clients make critical business decisions, and we are world class at creating strategies and valuations around products and markets which lead to growth and profitability. As clients look to build an optimal global portfolio, we support them to align corporate, therapeutic area and product strategies; to understand commercial potential, development risk and investment costs of their business decisions; and to gather unique local perspectives given our presence in established and emerging markets. We are industry pioneers in our work on portfolio management and emerging markets — transforming the way investment decisions are evaluated and implemented by our pharma, biotech and generics clients worldwide.